By Denny Jacob
Dentsply Sirona initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business.
Wellspect, a provider of bladder and bowel management care products, has an estimated $2 billion total addressable market, said Dentsply.
"We look forward to determining an outcome for Wellspect that supports the business' enhanced growth trajectory and success while also enabling Dentsply Sirona to focus our resources and attention on our dental business," said Chief Executive Simon Campion.
The manufacturer and producer of dental products and technologies said there's no deadline or definitive timetable to complete the strategic alternatives process, or guarantee it will result in a transaction.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
February 11, 2025 09:04 ET (14:04 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。